Studying Some Novel Biochemical and Immunological Markers in a Sample of Iraqi Women with Polycystic Ovarian Syndrome

Haneen Subhee Shaheed; Suzan Yousif Jasim; Wassan Abdul-Kareem Abbass

doi:10.5958/0974-360X.2020.00561.2

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Studying Some Novel Biochemical and Immunological Markers in a Sample of Iraqi Women with Polycystic Ovarian Syndrome

Author(s): Haneen Subhee Shaheed, Suzan Yousif Jasim, Wassan Abdul-Kareem Abbass

Email(s): ph.haneen2014@gmail.com , dr.suzany@uomustansiriyah.edu.iq , wassanabdulkareem@uomustansiryah.edu.iq

DOI: 10.5958/0974-360X.2020.00561.2

Address: Haneen Subhee Shaheed1*, Suzan Yousif Jasim2, Wassan Abdul-Kareem Abbass2
1Department of Pharmacy, Ashur University College, Baghdad-Iraq.
2Department of Clinical Laboratory Sciences, College of Pharmacy, Mustansiriyah University, Baghdad-Iraq.
*Corresponding Author

Published In: Volume - 13, Issue - 7, Year - 2020

View HTML

View PDF

ABSTRACT:
Polycystic ovarian syndrome (PCOS) considers as the most common disorder among women during reproductive age. Till now, the pathogenesis of PCOS stay unknown, and there is evidence considered PCOS as a low-grade inflammatory disease.The present study was designed to find out relationship of new biochemical markers, like fetuin-A, and immunological markers, like sirtuin-1, auto-antibodies (anti-histone antibody (AHA),anti-ovarian antibody (AOA)), and interleukins (IL-17, IL-23) with PCOS in studied patients when compared with healthy control group. Also, the study aimed to find the possible relationship between PCOS and autoimmunity.A total of 60 PCOS women and 30 healthy women, matching in average age and body mass index (BMI), were enrolled in this study. Women with PCOS were attend to AL - Nahrain University High Institute for Infertility Assisted Reproductive Technology, in Baghdad between Septembers to December / 2018. Blood samples were aspirated from both groups to study the biochemical and immunological markers byusing enzyme linked immunosorbent assay (ELISA).The obtained results showed highly significant elevation (P<0.01) in luteinizing hormone (LH) serum levels of patients group. Regarding the results of serum fetuin-A, sirtuin-1, auto-antibodies, and interleukins levels, highly significant differences were noticed between patients and control group (P<0.01). On the other hand, the LH recorded a direct correlation at highly significant level with sirtuin-1 and auto-antibodies (AH, AOA). Also LH showed a direct correlation at significant level with ILs (17, 23). Sirtuin-1 showed a direct correlation at highly significant level with auto-antibodies (AHA, AOA) and ILs (17, 23). Both auto-antibodies have direct correlation at highly significant level with ILs (17, 23) and with each other, in addition to their correlation with sirtuin-1, auto-antibodies (AHA, AOA) and LH. The current study showed that the studied markers were elevated significantly in patients group when compared with control. These findings confirm the possibility that PCOS may attributed to an autoimmune disease.

Keywords:

Cite this article:
Haneen Subhee Shaheed, Suzan Yousif Jasim, Wassan Abdul-Kareem Abbass. Studying Some Novel Biochemical and Immunological Markers in a Sample of Iraqi Women with Polycystic Ovarian Syndrome. Research J. Pharm. and Tech 2020; 13(7): 3171-3178. doi: 10.5958/0974-360X.2020.00561.2

Cite(Electronic):
Haneen Subhee Shaheed, Suzan Yousif Jasim, Wassan Abdul-Kareem Abbass. Studying Some Novel Biochemical and Immunological Markers in a Sample of Iraqi Women with Polycystic Ovarian Syndrome. Research J. Pharm. and Tech 2020; 13(7): 3171-3178. doi: 10.5958/0974-360X.2020.00561.2 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-7-21

REFERENCES:

1. Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction. 2016 Nov 17;31(12):2841-55.

2. Usama S, Umama S, Salma S, Mohammed N. Polycystic Ovary Syndrome (PCOS): A Thief of Womenhood. Asian J. Res. Pharm. Sci. 2018; 8(2):68-72.

3. Bellver J, Rodríguez-Tabernero L, Robles A,Robles A, Muñoz E, Martínez F, Landeras J, García-Velasco J Fontes J, Álvarez M, Alvarez C, Acevedo B. Polycystic ovary syndrome throughout a woman’s life. Journal of Assisted Reproduction and Genetics. 2018 Jan 1;35(1):25-39.

4. Polak K, Czyzyk A, Simoncini T, Meczekalski B. New markers of insulin resistance in polycystic ovary syndrome. Journal of Endocrinological Investigation. 2017 Jan 1;40(1):1-8.

5. Salman KE, Altunay IK, Kucukunal NA, Cerman AA. Frequency,severity and related factors of androgenetic alopecia in dermatology outpatient clinic: hospital-based cross-sectional study in Turkey. Anais Brasileiros de Dermatologia. 2017 Feb; 92(1):35-40.

6. Asha K, Veena G. Effectiveness of Structured Teaching Programme (STP) on Knowledge regarding Polycystic Ovarian Syndrome (PCOS) among Adolescent Girls, Kollam. Int. J. Nur. Edu. and Research. 2018; 6(4):360-362.

7. hushboo B,Tarundeep K, P. Vadivukarrasi R . Knowledge regarding Poly Cystic Ovarian Syndrome (PCOS) among the Teenage Girls. Int. J. Nur. Edu. and Research. 2016; 4(2):136-140.

8. Kachuei M, Jafari F, Kachuei A, Keshteli AH. Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Archives of Gynecology and Obstetrics. 2012 Mar 1;285(3):853-6.

9. M. Vijey Aanandhi, Meha John. The Role of Thyroid Dysfunction and The Importance of Conducting Regular Thyroid Function Tests in patients with PCOS: A Narrative Review. Research J. Pharm. and Tech 2018; 11(12): 5672-5674.

10. Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertility and Sterility. 2016 Jul 1;106(1):6-15.

11. Anuchithra R. Polycystic Ovarian Syndrome (PCOS) in Adolescence. Asian J. Nur. Edu. & Research. 2012 April-June; 2(2): 55-64.

12. Nickerson BS, Esco MR, Bishop PA, Fedewa MV, Snarr RL, Kliszczewicz BM,Park KS. Validity of BMI-based body fat equations in men and women: A 4-compartment model comparison. The Journal of Strength & Conditioning Research. 2018 Jan 1;32(1):121-9.

13. Statistical Analysis System, User's Guide. Statistical. SAS. 2012. Version 9.1th ed. SAS. Inst. Inc. Cary. N.C. USA.

14. Stein IF. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29:181-91.

15. Sova H, Unkila-Kallio L, Tiitinen A,Hippeläinen M, Perheentupa A, Tinkanen H, Puukka K, Bloigu R, Piltonen T, Tapanainen JS, Morin-Papunen L. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes. Gynecological Endocrinology. 2019 Jan 22:1-6.

16. Revathi. R, Julius. A. Effect of LH/FSH Ratio and its Correlation with Insulin Resistance in PCOS Obese woman of Reproductive age Group. Research J. Pharm. and Tech 2018; 11(6): 2217-2219.

17. Le MT, Le VN, Le DD, Nguyen VQ, Chen C, Cao NT. Exploration of the role of anti‐Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome. Clinical Endocrinology. 2019 Apr;90(4):579-85.

18. Maruo S, Mori K, Motoyama K, Nakamura M, Kawarabayashi R, Kakutani Y, Yamazaki Y, Morioka T, Shoji T, Inaba M, Emoto M. Correlation analysis of monocyte subsets and insulin resistance considering fetuin-A involvement in patients with type 2 diabetes. Clinical and Translational medicine. 2018 Dec;7(1):9.

19. Kaushik SV, Plaisance EP, Kim T,Huang EY, Mahurin AJ, Grandjean PW,Mathews ST. Extended‐release niacin decreases serum fetuin‐A concentrations in individuals with metabolic syndrome. Diabetes/metabolism Research and Reviews. 2009 Jul;25(5):427-34.

20. Kiyak Caglayan E, Engin-Ustun Y, Gocmen AY,Polat MF, Aktulay A. Serum sirtuin 1 levels in patients with polycystic ovary syndrome. Journal of Obstetrics and Gynaecology. 2015 Aug 18;35(6):608-11.

21. Gao T, Li MT, Hou TY, Yang Y. The Roles of Sirtuins in DNA Damage and Repair. Sheng li ke xue jin zhan Progress in Physiology. 2016 Aug; 47(4):249-54.

22. Li JY, Wu X, Gillilland M, Zhou SY, Owyang C. High-Fat Feeding Enhances Stemness of Intestinal Progenitors and Stimulates Epithelial Proliferation via Upregulation of R-Spondin 3 and its Receptors LGR4 and 5. Gastroenterology. 2017 Apr 1;152(5):S252.

23. Samsami DA, Razmjoei P, Parsanezhad ME. Serum levels of anti-histone and anti-double-strand DNA antibodies before and after laparoscopic ovarian drilling in women with polycystic ovarian syndrome. The Journal of Obstetrics and Gynecology of India. 2014 Feb 1;64(1):47-52.

24. Hefler-Frischmuth K, Walch K, Huebl W. Serologic markers of autoimmunity in women with polycystic ovary syndrome. Fertility and Sterility. 2010 May 1;93(7):2291-4.

25. Rashid A, Bhat JA, Ganie MA, Wani IA, Bhat MH, Shah ZA,Masoodi SR, Marwaha RK.Evaluation of serum anti-nuclear antibody among women with PCOS: a hospital based single center cross sectional study. Gynecological Endocrinology. 2018 May 7:1-5.

26. Tanguturi SC, Nagarakanti S. Polycystic ovary syndrome and periodontal disease: Underlying links-A review. Indian Journal of Endocrinology and Metabolism. 2018 Mar;22(2):267.

27. Xiao N, He K, Gong F,Xie Q, Peng J, Su X, Lu Y, Xia X, Lin G, Cheng L.Altered subsets and activities of B lymphocytes in polycystic ovary syndrome. Journal of Allergy and Clinical Immunology. 2019 Jan 21.

28. Karakose M, Demircan K, Tutal E, Demirci T, Arslan MS, Sahin M, Celik HT, Kazanci F, Karakaya J, Cakal E, Delibasi T. Clinical significance of Adamts1, Adamts 5, Adamts 9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome. Journal of Endocrinological Investigation. 2016 Nov 1;39(11):1269-75.

29. Daan NM, Koster MP, de Wilde MA. Biomarker profiles in women with PCOS and PCOS offspring; a pilot study. PloS one. 2016 Nov 2;11(11):e0165033.

30. Shoenfeld Y, Segol O. Anti-histone antibodies in SLE and other autoimmune diseases. Clinical and Experimental Rheumatology. 1989;7(3):265-71.

31. Chang CH, Hansen HJ, Goldenberg DM, inventors; Immunomedics, Inc., assignee. Chimeric and humanized anti-histone antibodies. United States Patent Application US 15/887,488. 2018 Aug 7.

32. Walch K, Grimm C, Zeillinger R, Huber JC, Nagele F, Hefler LA. A common interleukin-6 gene promoter polymorphism influences the clinical characteristics of women with polycystic ovary syndrome. Fertility and Sterility. 2004 Jun 1;81(6):1638-41.

33. Alvarez Y, Rodríguez M, Municio C, Hugo E, Alonso S, Ibarrola N,Fernández N, Crespo MS. Sirtuin 1 is a key regulator of the interleukin-12 p70/interleukin-23 balance in human dendritic cells. Journal of Biological Chemistry. 2012 Oct 12;287(42):35689-701.

34. Abraham S, Barton A, Eder L, Lim A, McGonagle D, McHugh N, Pennington S, Sengupta R, Siebert S, Bowness P, Schafer PH.Advancing research paradigms and pathophysiological pathways in psoriatic arthritis and ankylosing spondylitis: Proceedings of the 2017 Platform for the Exchange of Expertise and Research (PEER) meeting. In Seminars in Arthritis and Rheumatism 2018 Oct 15. Elsevier.

35. Motamedzadeh L, Mohammadi MM, Hadinedoushan H, Farashahi Yazd E, Fesahat F. Association of IL-17 and IL-23 follicular fluid concentrations and gene expression profile in cumulus cells from infertile women at risk for ovarian hyperstimulation syndrome. Human Fertility. 2019 Feb 1:1-7.